TMFEBCapital

Todd Campbell

TMFEBCapital’s Activity

Today

NL

Article

EBCapitalMarkets published an article 12:52 PM

Could This 1 Lawsuit Destroy Biogen Idec Stock?

Sanofi (SNY) and Novartis (NVS) generic units are among those challenging the dosing patent on Biogen's (BIIB) Tecfidera.

NL

Article

EBCapitalMarkets published an article 10:57 AM

5 Key Ways for Laboratory Corp Stock to Win

Here are the five goals CEO David King thinks Laboratory Corp (LH) will need to execute on if the company hopes to grow.

Yesterday

NL

Article

EBCapitalMarkets published an article 2:46 PM

Revenue Up 27%: Time to Buy Athenahealth Stock?

Athenahealth posted solid sales growth in the second quarter as it won share from Allscripts and Quality Systems, but investors are right to worry over lackluster earnings.

Thu Jul 17

NL

Article

EBCapitalMarkets published an article 10:01 PM

Obamacare's Medicaid Expansion a Slam Dunk for UnitedHealth Group

UnitedHealth Group signed up more than 380,000 new members through Medicaid in the second quarter, suggesting that similarly strong results will be posted by competitors Aetna (AET) and WellPoint (WLP)

NL

Article

EBCapitalMarkets published an article 4:18 PM

Are Insurers Playing Fair With HIV Patients?

Insurers Aetna (AET), Cigna (CI), and Humana (HUM) are on the hot seat over how much they'll pay for HIV drugs like those made by Gilead (GILD).

NL

Article

EBCapitalMarkets published an article 1:17 PM

The Implications of Obesity as a Disability in Europe

Despite rising obesity in Europe, the EU has yet to approve weight loss drugs from Arena (ARNA), Vivus (VVUS), or Orexigen (OREX).

NL

Article

EBCapitalMarkets published an article 10:37 AM

Why Growth Is Coming to Abbott Laboratories Stock

Here's what you need to know about Abbott Laboratories second-quarter results and its outlook for the rest of this year.

Wed Jul 16

NL

Article

EBCapitalMarkets published an article 6:47 PM

Everything is Bigger in Texas...Including Medicaid

Medicaid enrollment has climbed by 80,000 in Texas despite the state opting out of Medicaid expansion.

NL

Article

EBCapitalMarkets published an article 4:01 PM

Is Obamacare Behind HCA Stock's Surprising Surge?

HCA (HCA) pre-released its second quarter results today, sending shares significantly higher.

NL

Article

EBCapitalMarkets published an article 2:24 PM

Do Johnson & Johnson's Results Suggest a Pop or Drop for Gilead Sciences?

Johnson & Johnson sold $831 million worth of Olysio in the second quarter, twice as much as in the first quarter; but that may not mean that sales of Gilead's (GILD) Sovaldi doubled, too.

NL

Article

EBCapitalMarkets published an article 11:22 AM

What You Need to Know About Johnson & Johnson's Best-Selling Drugs

Johnson & Johnson's new drugs are driving sales growth; but new competition from AbbVie and Bristol-Myers Squibb create risk.

Tue Jul 15

NL

Article

EBCapitalMarkets published an article 5:20 PM

Will Incoming Competition Derail Aegerion Stock?

A new class of cholesterol drugs including Amgen's (AMGN) evolocumab could soon be competing for Aegerion's (AEGR) market share in HoFH patients.

NL

Article

EBCapitalMarkets published an article 5:00 PM

What You Need To Know Ahead of UnitedHealth Group's Earnings

Here's what you should be looking for when UnitedHealth Group (UNH) reports earnings on July 17th.

NL

Article

EBCapitalMarkets published an article 3:11 PM

Will Centene's Earnings Disappoint?

Centene (CNC) is enjoying significant enrollment growth thanks to Medicaid expansion. Here's what you need to know heading into Centene's second-quarter earnings.

NL

Article

EBCapitalMarkets published an article 1:35 PM

Surging Medicaid = Insurer Earnings Surprise?

More than 6 million have signed up for Medicaid since the ACA launched, providing significant revenue opportunity for UnitedHealth Group (UNH), Aetna (AET), Molina (MOH), and Centene (CNC).

NL

Article

EBCapitalMarkets published an article 11:42 AM

5 Novartis Questions We Need Answered

Here's what you need to be asking Novartis (NVS) during its second quarter earnings conference call.

NL

Article

EBCapitalMarkets published an article 10:08 AM

Will Athenahealth Stock Win Over Doubters?

Here are the background and key considerations heading into Athenahealth's second-quarter earnings.

NL

Article

EBCapitalMarkets published an article 8:49 AM

Mylan and Abbott Just Got More Interesting

Here's what you need to know about Abbott selling part of its drug business to Mylan in a deal worth $5.3 billion.

Mon Jul 14

NL

Article

EBCapitalMarkets published an article 12:03 PM

What You Need to Know Ahead of Abbott Labs Earnings

Abbott Labs (ABT) is reporting earnings on July 16.

NL

Article

EBCapitalMarkets published an article 11:50 AM

Peregrine Earnings Today: 3 Questions That Need Answers

Here's what you should be looking for in Peregrine's second quarter earnings when they're released after the bell on July 14.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 65486 out of 75001
Score -363.19
Score Change Today -2.94
Accuracy 29.41%
Active Picks 34
Total Picks 34
Best Pick GILD (+35.60)
Worst Pick WFM (-50.83)
Average Score per Pick -10.68
Charms Earned 5
Highest Rated Favorite No Favorites Selected
Go to TMFEBCapital’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFEBCapital’s 10 Latest Posts